HomeKLRS • NASDAQ
Kalaris Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.13M | 105.92% |
Net income | -22.03M | 63.10% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -19.42M | 55.55% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.64M | -48.28% |
Total assets | 118.55M | 3,456.74% |
Total liabilities | 56.78M | 1,340.36% |
Total equity | 113.31M | — |
Shares outstanding | 18.70M | — |
Price to book | -0.52 | — |
Return on assets | -40.49% | — |
Return on capital | -41.64% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -22.03M | 63.10% |
Cash from operations | -7.85M | -89.82% |
Cash from investing | 5.00M | -80.17% |
Cash from financing | 7.58M | 10.47% |
Net change in cash | 1.43M | -47.37% |
Free cash flow | 2.50M | 114.95% |
Previous close
$7.40
Day range
$7.08 - $7.70
Year range
$7.08 - $24.15
Market cap
131.17M USD
Avg Volume
12.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2013
Headquarters
Website
Employees
14
